Luis Figueroa
Hematology & Oncology · Canovanas, PRNPI 1013263060
Payments from drug & device makers
Across 78 payments — averaging $20.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$209
- Amgen$207
- AstraZeneca$193
- Johnson & Johnson$139
- Novartis$126
- Merck$120
- plus $635 from 17 others
What the payments were for
- Food & beverage$1,627100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 9 | $209 |
| Amgen | 10 | $207 |
| AstraZeneca | 9 | $193 |
| Johnson & Johnson | 7 | $139 |
| Novartis | 5 | $126 |
| Merck | 6 | $120 |
| Genentech USA, Inc. | 6 | $93 |
| Bristol Myers Squibb | 4 | $84 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $64 |
| GSK | 3 | $56 |
| AbbVie | 2 | $50 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Sanofi | 1 | $26 |
| Taiho Oncology, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $25 |
| Clovis Oncology, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Seagen Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Pfizer Pharmaceuticals LLC | 1 | $13 |
How this compares
$1,627 in reported general payments places this provider in the 15th percentile of 138 hematology & oncology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 41 | $513,505 |
| TagrissoOsimertinib Mesylate | 12 | $198,449 |
| SprycelDasatinib | 11 | $194,486 |
| XtandiEnzalutamide | 13 | $183,781 |
| RetacritEpoetin Alfa-Epbx | 43 | $106,965 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $128 |
| Prednisone | 20 | $86 |
| Tramadol Hcl | 16 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bristol Myers SquibbRevlimid | $84 | $513,50541 claims |
| AstraZenecaTagrisso | $193 | $198,44912 claims |
| E.r. Squibb & Sons, L.L.C.Sprycel | $209 | $194,48611 claims |
| PfizerRetacrit | $17 | $106,96543 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 138 hematology & oncology providers in Puerto Rico.
Other hematology & oncology in Canovanas
- Mirelis AcostaSan Juan$6.3M
- Hector Velez CortesPonce$3.1M
- Luis FloresSan Juan$2.3M
- Noridza Rivera RodriguezSan Juan$2.1M
- Adelba Torres-LopezSan Juan$1.9M
- Maria Garcia PallasCaguas$1.8M
- Karina Arocho-GonzalezHato Rey$1.1M
- Jose Lozada CostasSan Juan$934K
- Fernando CabanillasSan Juan$916K
- Mayra Rivera FigueroaRio Piedras$745K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.